Edmond de Rothschild

Welcome to our Fund Center

This site provides extensive information about the ranges of Edmond de Rothschild Group funds. In particular, it provides simplified access to key fund-related data (performance, net asset values, features) and their commercial or legal documents.

Please enter your country and indicate which investor category you belong to:
Mobile Logo

EdR Fund US Value US equities

US equities
Change in NAV (21/02/2018)
111.07 EUR
Christophe  FOLIOT–LU1170683236–
Christophe FOLIOT
Adeline SALAT-BAROUX–LU1170683236–
Adeline SALAT-BAROUX
The identity of the managers presented in this document may change during the life of the product.
Risk and reward profile (1)
1234567
Recommended holding period
> 5 years
111.07 EUR
Change in NAV (21/02/2018)
6
1234567
Risk and reward profile
> 5 years
Recommended holding period
Change in NAV (21/02/2018)
111.07 EUR
Risk and reward profile
1234567
Recommended holding period
> 5 years
Christophe FOLIOT  
Adeline SALAT-BAROUX  
The identity of the managers presented in this document may change during the life of the product.
Contact

Investment objective

The Sub-Fund actively selects undervalued and recovery stocks that have a healthy balance sheet and whose prospects are improving. The Sub-Fund is invested in North American large capitalisations.

View more View less

Commentary 31/01/2018

The elements of a reflationary scenario seem to be reviving investor interest with the yield on the benchmark US 10-year T-bond climbing from 2.4% to 2.7% in a month, and oil continuing to recover. Defensive sectors are accordingly being penalised with utilities, real estate, telecoms and consumer staples underperforming. Still, market leadership has not changed since 2017. Growth strategies continue to outperform the market as well as Value, still 3% off this month, while consumer discretionaries and technology still lead on the equity markets. EdR US Value & Yield climbed modestly in January, impacted by the decline in the US dollar while also benefiting from the performance of our health, energy and commodities stocks. In addition, we took advantage of the rebound made by Bombardier, which will not, after all, be subject to punitive tariffs in the wake of a favourable US court ruling. During the month, we did some arbitraging in the healthcare sector, selling the US healthcare mutual Centene, which was revalued on an improvement in its operating results and the positive impact of the US tax reforms. A position was initiated on Zimmer Biomet, in the medical prostheses business, as its stock price was impacted by production problems which are currently being resolved. Meanwhile, the cash reserve has risen thanks to profit-taking on Caterpillar and Bank of New York.

View more View less

Change in NAV

Chart – Base 100 (21/02/2018)
Avertissement
You are about to download the historical data for a portfolio. Please note that past performance is not an indication of future performance and it may vary over time. They may be affected, for example, by changes in exchange rates

Performance N-EUR Cumulative Annualised
Since 01/01/2018

-2.45 %

-1.33 %

-2.45 %

-1.33 %

1 Year

-10.17 %

-0.96 %

-10.17 %

-0.96 %

3 Year

5.42 %

23.41 %

1.77 %

7.25 %

Since inception

11.07 %

28.35 %

3.50 %

8.53 %

Since 01/01/2018 1 Year 3 Year 5 year Since inception
Cumulative

Share class (N-EUR)

Benchmark

-2.45 %

-1.33 %

-10.17 %

-0.96 %

5.42 %

23.41 %

11.07 %

28.35 %

Annualised

Share class (N-EUR)

Benchmark

-10.17 %

-0.96 %

1.77 %

7.25 %

3.50 %

8.53 %

*Rolling periods

Annual performance



Statistics

VolatilityTracking ErrorCorrelation coefficientInformation ratioSharpe ratio
Share class N-EURBenchmarkShare class N-EURBenchmarkShare class N-EURBenchmarkShare class N-EURBenchmarkShare class N-EURBenchmark
1 Year*11.84 %9.54 %6.22 %0.85 %-1.61 %0.87 %
3 Year *
Max. drawdownAlphaBeta
Share class N-EURBenchmarkShare class N-EURBenchmarkShare class N-EURBenchmark
1 Year*-17.50 %-0.19 %1.06 %
3 Year *
Max. monthly gain Since inception23.72 %
Max. monthly loss Since inception-15.30 %
Share class N-EUR
Benchmark
1 Year* 3 Year * 1 Year* 3 Year *
Volatility 11.84 % 9.54 %
Tracking Error 6.22 %
Sharpe ratio 0.87 %
Alpha -0.19 %
Correlation coefficient 0.85 %
Information ratio -1.61 %
Max. monthly loss -15.30 %
Max. monthly gain 23.72 %
Max. drawdown -17.50 %
Beta 1.06 %

Fund information

Inception Date (Fund)
28/12/2000
Inception Date (Part)
04/02/2015
Legal form
SICAV
Benchmark
S&P 500 (NR)
Currency (fund)
EUR
Currency (share class)
EUR
Distribution Policy
Accumulation
Valuation frequency
Daily
Minimum initial investment
5000000.00 EUR
ISIN Code
LU1170683236
AuM (fund)
820 M (EUR)
Regulatory authority
CSSF
EU Regulation
UCITS
Management company
Edmond de Rothschild Asset Management (Luxembourg)
Delegated Management Company
Edmond de Rothschild Asset Management (France)
Incorporation
Luxembourg
Maximum management fee
0,550 %
Current management fee
0.550 %
Subscription and redemption conditions
Daily before 12.30 am C.E.T. on day's net asset value

Fund documentation

Select all

(1) The rating grades the funds on a scale from 1 to 7. This rating system is based on the average fluctuations of the net asset value over the past five years. It corresponds to the variation range of the portfolio upwards and downwards. If the net asset value is less than 5 years old, the rating is determined by other regulatory calculation methods. Historical data such as those used to calculate the rating may not be a reliable indication of the future risk profile. The current category is neither a guarantee nor an objective. Category 1 does not signify a risk-free investment.

Top